Skip to main content

Table 2 Follow-up data (FU)

From: Pacing-induced cardiomyopathy in chronic right ventricular apical pacing: a midterm follow-up study

FU Non-PICM PICM p value
SR 13.2% 18.2% 0.64
DR 86.8% 81.8% 0.65
LVEF-FU (%± SD) 65 (± 8.5) 38 (± 4.6) 0.01
ΔLVEF 2.3 (± 9.9) 20.4 (± 7.9) < 0.0001
RV-PACE% 50 (± 40) 70 (± 30) 0.10
ACEI 56.6% 54.5% 0.84
ARB 30.2% 36.4% 0.74
MRA 75% 25% 0.03
BB 76.1% 81.8% 0.5
CCB 27.7% 9.1% 0.29
Digitoxin 5% 9.1% 0.46
  1. SR single-chamber pacemaker, DR double-chamber pacemaker, medication: ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, MRA mineralocorticoid receptor antagonist, BB beta-blocker, CCB calcium canal blocker